Francis K L Chan Selected Research

Omeprazole (Prilosec)

7/2010	Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
1/2010	A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract.
4/2007	Omeprazole before endoscopy in patients with gastrointestinal bleeding.
10/2004	Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.
8/2003	The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison.
12/2002	Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
1/2002	Helicobacter pylori, NSAIDs and gastrointestinal haemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francis K L Chan Research Topics

Disease

38	Hemorrhage 02/2022 - 01/2002
35	Ulcer 05/2020 - 01/2002
22	Neoplasms (Cancer) 01/2022 - 06/2003
18	Stomach Neoplasms (Stomach Cancer) 01/2022 - 06/2003
18	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 06/2003
16	Peptic Ulcer (Peptic Ulcers) 01/2020 - 09/2002
16	Infections 07/2018 - 01/2002
10	Carcinogenesis 01/2020 - 08/2006
7	COVID-19 05/2022 - 01/2020
6	Ulcerative Colitis 07/2022 - 06/2012
6	Colonic Neoplasms (Colon Cancer) 01/2015 - 12/2012
5	Inflammation (Inflammations) 12/2019 - 01/2015
5	Dyspepsia (Indigestion) 12/2018 - 01/2002
4	Gastroesophageal Reflux (GERD) 01/2020 - 04/2002
4	Duodenal Ulcer (Curling's Ulcer) 01/2020 - 01/2003
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 09/2011
4	Crohn Disease (Crohn's Disease) 12/2019 - 06/2012
4	Arthritis (Polyarthritis) 06/2017 - 12/2002
3	Polyps 01/2022 - 05/2012
3	Hypertension (High Blood Pressure) 01/2020 - 12/2002
3	Tuberculosis (Tuberculoses) 01/2019 - 09/2014
3	Clostridium Infections 01/2019 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2017 - 02/2015
3	Adenoma (Adenomas) 01/2017 - 08/2009
3	Rheumatoid Arthritis 11/2011 - 01/2010
3	Carcinoma (Carcinomatosis) 05/2005 - 08/2002
2	Dysbiosis 05/2022 - 10/2018
2	Colitis 01/2021 - 07/2006
2	Stomach Ulcer (Gastric Ulcer) 01/2020 - 06/2017
2	Shock 01/2020 - 03/2009
2	Constipation 12/2018 - 07/2006
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2018 - 01/2010
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2016 - 11/2014
2	Gastritis 02/2016 - 01/2003
2	Latent Tuberculosis 01/2016 - 11/2014
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 09/2013 - 07/2006
2	Acute Coronary Syndrome 02/2012 - 11/2011
2	Osteoarthritis 07/2010 - 01/2010
2	Myocardial Infarction 01/2008 - 10/2006
2	Metaplasia 08/2006 - 08/2002

Drug/Important Bio-Agent (IBA)

27	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2020 - 01/2002
22	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2020 - 01/2002
20	Proton Pump InhibitorsIBA 01/2022 - 12/2002
16	Pharmaceutical PreparationsIBA 11/2022 - 10/2004
10	Biomarkers (Surrogate Marker)IBA 05/2022 - 07/2004
9	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020 - 01/2003
8	AnticoagulantsIBA 01/2022 - 01/2008
7	Misoprostol (Cytotec)FDA LinkGeneric 05/2020 - 01/2005
7	Proteins (Proteins, Gene)FDA Link 12/2019 - 12/2007
7	Clopidogrel (Plavix)FDA Link 01/2019 - 01/2005
7	Omeprazole (Prilosec)FDA LinkGeneric 07/2010 - 01/2002
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2003
6	Celecoxib (Celebrex)FDA Link 06/2017 - 12/2002
5	Messenger RNA (mRNA)IBA 01/2022 - 12/2007
5	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2020 - 11/2003
5	Esomeprazole (Nexium)FDA Link 06/2017 - 01/2005
5	MicroRNAs (MicroRNA)IBA 02/2015 - 05/2012
5	Diclofenac (SR 38)FDA LinkGeneric 11/2010 - 12/2002
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2017
4	AcidsIBA 01/2022 - 01/2005
4	Famotidine (Pepcid)FDA LinkGeneric 01/2020 - 11/2011
4	AzoxymethaneIBA 01/2020 - 12/2012
4	CateninsIBA 01/2019 - 06/2013
4	Capsules (Microcapsules)IBA 10/2018 - 09/2012
4	Naproxen (Naprosyn)FDA LinkGeneric 06/2017 - 01/2003
4	CathelicidinsIBA 02/2016 - 12/2012
4	rofecoxib (Vioxx)FDA Link 11/2011 - 01/2003
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2007 - 12/2002
3	Hemostatics (Antihemorrhagics)IBA 02/2022 - 01/2010
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 04/2015
3	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2012
3	Hemoglobins (Hemoglobin)IBA 12/2019 - 01/2017
3	CaspasesIBA 01/2015 - 12/2012
3	Transcription Factors (Transcription Factor)IBA 11/2014 - 06/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022 - 11/2011
2	hemosprayIBA 02/2022 - 12/2019
2	PowdersIBA 02/2022 - 12/2019
2	SteroidsIBA 01/2022 - 07/2016
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 01/2002
2	ProstaglandinsIBA 05/2020 - 01/2003
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2018 - 07/2018
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2018 - 01/2018
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018 - 01/2018
2	CytokinesIBA 12/2017 - 10/2015
2	Biological ProductsIBA 10/2015 - 02/2009
2	Sucrose (Saccharose)IBA 02/2015 - 06/2003
2	Interferon-gamma (Interferon, gamma)IBA 11/2014 - 09/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2014 - 06/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2013 - 04/2005
2	3' Untranslated Regions (3' UTR)IBA 02/2013 - 01/2013
2	LuciferasesIBA 02/2013 - 01/2013
2	AntigensIBA 06/2012 - 04/2007

Therapy/Procedure

39	Therapeutics 05/2022 - 04/2002
3	Transplantation 01/2022 - 01/2018
2	Blood Transfusion (Blood Transfusions) 02/2022 - 12/2019
2	Fecal Microbiota Transplantation 01/2021 - 10/2018
2	Endoscopic Hemostasis 07/2014 - 03/2009
2	Dual Anti-Platelet Therapy 08/2012 - 02/2012
2	Stents 02/2012 - 07/2005
2	Ligation 07/2005 - 07/2004